Clinical Trial Detail

NCT ID NCT01393509
Title The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors Memorial Sloan-Kettering Cancer Center
Indications

lymphoma

Advanced Solid Tumor

Therapies

PU-H71

Age Groups: senior adult

No variant requirements are available.